The movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study

The movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study

Opis bibliograficzny
Główni autorzy:	Varley, J, Webb, A, Balint, B, Fung, V, Sethi, K, Tijssen, MAJ, Lynch, T, Mohammad, SS, Britton, F, Evans, M, Hacohen, Y, Lin, JP, Nardocci, N, Granata, T, Dale, RC, Lim, M, Bhatia, K, Lang, A, Irani, SR
Format:	Journal article
Wydane:	BMJ Publishing Group 2018

Podobne zapisy

The movement disorder associated with NMDAR-antibody encephalitis: an expert-rater video study
od: Varley, JA, i wsp.
Wydane: (2016)

Comparison of antibody assays in anti-NMDAR encephalitis
od: Gastaldi, M, i wsp.
Wydane: (2016)

Ongoing germinal centre reactions contribute to N-methyl-D-aspartate receptor (NMDAR) antibody production in nmdar-antibody encephalitis
od: Makuch, M, i wsp.
Wydane: (2018)

HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis
od: Peris Sempere, V, i wsp.
Wydane: (2024)

Detection of NMDARs antibodies in encephalitis
od: Gastaldi, M, i wsp.
Wydane: (2017)

In vivo n-methyl-d-aspartate receptor (NMDAR) density as assessed using positron emission tomography during recovery from NMDAR-antibody encephalitis
od: Galovic, M, i wsp.
Wydane: (2022)

NMDAR-antibody encephalitis: psychopathology and immunobiology
od: Al-Diwani, A
Wydane: (2020)

Anti-NMDAR encephalitis misdiagnosed as Hashimoto's encephalopathy.
od: Mirabelli-Badenier, M, i wsp.
Wydane: (2014)

Anti-NMDAR encephalitis misdiagnosed as Hashimoto's encephalopathy
od: Mirabelli-Badenier, M, i wsp.
Wydane: (2014)

Dysplastic Neurons in Ovarian Teratomas in NMDAR Encephalitis
od: J Gordon Millichap, i wsp.
Wydane: (2014-08-01)

Clinical Features of NMDAR Ab-mediated Encephalitis
od: J Gordon Millichap, i wsp.
Wydane: (2015-06-01)

HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis
od: Vicente Peris Sempere, i wsp.
Wydane: (2024-07-01)

Anti-NMDAR Encephalitis developing neuroleptic malignant syndrome
od: Amandeep Singh Dhaliwal, i wsp.
Wydane: (2024-08-01)

IRAK4 deficiency presenting with anti-NMDAR encephalitis and HHV6 reactivation
od: Nishimura, S, i wsp.
Wydane: (2020)

The immunopathogenesis of ovarian teratoma-associated NMDAR-antibody encephalitis: mechanisms of B Cell immunoreactions inform a rational approach to gynaecologic operative management
od: Al-Diwani, A, i wsp.
Wydane: (2020)

Autoimmune encephalitis: recent clinical and biological advances
od: Varley, JA, i wsp.
Wydane: (2023)

Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies.
od: Pellkofer, H, i wsp.
Wydane: (2010)

A case of NMDAR Encephalitis with muscular pain as the main presentation
od: Baizhu Li, i wsp.
Wydane: (2024-04-01)

Psychiatric features of two cases of anti-NMDAR autoimmune encephalitis
od: Bárbara Ferreira Althoff, i wsp.
Wydane: (2024-03-01)

Clinical data and reporting quality in NMDAR-antibody encephalitis and pregnancy: a systematic review
od: Sarosh R Irani, i wsp.
Wydane: (2025-03-01)

The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data
od: Al-Diwani, A, i wsp.
Wydane: (2019)

Case-series of patients treated with anti-NMDAR encephalitis at Semmelweis University
od: L. Herman, i wsp.
Wydane: (2024-04-01)

Finding the Cause of Psychosis: A Challenging Case of Anti-NMDAR Encephalitis
od: Bhanu R. Sabbula, i wsp.
Wydane: (2020-01-01)

Autoimmune encephalitis
od: Irani, SR
Wydane: (2024)

Criminality in patients with autoimmune encephalitis: a case series
od: Michael, S, i wsp.
Wydane: (2024)

On being autoimmune in psychiatric places: 10 characteristic mental state features in patients with definite NMDAR-antibody encephalitis
od: Al-Diwani, A, i wsp.
Wydane: (2019)

The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series
od: Wenlin Wu, i wsp.
Wydane: (2024-12-01)

Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitis
od: Sarah Jesse, i wsp.
Wydane: (2024-12-01)

Post-Herpetic Anti-NMDAR Encephalitis in Denmark: Current Status and Future Challenges
od: Anna Søgaard, i wsp.
Wydane: (2024-08-01)

CIELO: a randomized, double-blind, placebo-controlled, phase 3 basket study of satralizumab in patients with NMDAR- or LGI1-antibody encephalitis
od: Gelfand, JM, i wsp.
Wydane: (2022)

Increased serum phenylalanine/tyrosine ratio associated with the psychiatric symptom of anti-NMDAR encephalitis
od: Jia Ma, i wsp.
Wydane: (2024-10-01)

Recurrent Anti-NMDAR Encephalitis Necessitating Oophorectomy in an Adolescent Patient: A Case Report
od: Shadowen Caroline, i wsp.
Wydane: (2024-01-01)

Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis
od: Jeremy Chataway, i wsp.
Wydane: (2021-06-01)

CSF Findings in Chinese Patients with NMDAR, LGI1 and GABABR Antibody-Associated Encephalitis
od: Qiao S, i wsp.
Wydane: (2024-03-01)

CSF Mitochondrial N-Formyl Methionine Peptide as Complementary Diagnostic Tool in Anti-NMDAR Encephalitis and Anti-LGI1 Encephalitis
od: Li C, i wsp.
Wydane: (2024-12-01)

NMDA receptor antibody related encephalitis
od: Irani, SR
Wydane: (2012)

Potentially pathogenic autoantibodies associated with epilepsy and encephalitis in children and adults.
od: Vincent, A, i wsp.
Wydane: (2011)

Autoimmune encephalitis.
od: Irani, SR, i wsp.
Wydane: (2011)

Autoimmune encephalitis
od: Irani, SR, i wsp.
Wydane: (2011)

Hunting the origin and source of NR1-directed IgGs in patients with encephalitis
od: Cleaver, J, i wsp.
Wydane: (2024)